Whiz Partners is a private equity and venture capital firm that invests in the healthcare industry.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Whiz Partners is a private equity and venture capital firm that invests in the healthcare industry.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2012 | SymBio Pharmaceuticals | Post-IPO Equity | 11.7M |
10/2017 | Inspec | Post-IPO Equity | 48k |
3/2014 | CellSeed | Post-IPO Equity | 5M |
12/2019 | Caresyntax | Equity | 45.6M |
5/2015 | DIGITAL HEARTS HOLDINGS | Post-IPO Debt | 8.5M |
11/2015 | CRI Middleware Co., Ltd. | Post-IPO Debt | 5.3M |
10/2017 | CLARRO Inc. | Post-IPO Debt | 0 |
4/2016 | SymBio Pharmaceuticals | Post-IPO Debt | 0 |
2/2013 | Gene Techno Science | Post-IPO Equity | 13.2M |
5/2010 | SymBio Pharmaceuticals | Venture Round | 5.9M |
8/2014 | Shoubunsha Publications | Post-IPO Equity | 9.8M |
9/2018 | WHILL | Series C | 0 |
9/2015 | NanoCarrier Co | Post-IPO Debt | 25.7M |
4/2017 | Tocagen | Post-IPO Equity | 0 |
12/2016 | Immuno-Biological Laboratories | Post-IPO Debt | 0 |
11/2016 | ALBERT | Post-IPO Debt | 0 |
6/2016 | Medrx | Post-IPO Debt | 0 |
1/2012 | NanoCarrier Co | Post-IPO Debt | 22.1M |
9/2015 | Medinet Co | Post-IPO Equity | 4.3M |
4/2014 | Nanodex | Venture Round | 406.1k |
11/2016 | FRONTEO | Post-IPO Debt | 0 |
5/2013 | Advanced Media | Post-IPO Equity | 15.3M |
12/2019 | Caresyntax | Series B | 0 |
9/2018 | WHILL | Series C | 0 |
10/2017 | Inspec | Post-IPO Equity | 0 |
10/2017 | CLARRO Inc. | Post-IPO Debt | 0 |
4/2017 | Tocagen | Post-IPO Equity | 0 |
12/2016 | Immuno-Biological Laboratories | Post-IPO Debt | 0 |
11/2016 | ALBERT | Post-IPO Debt | 0 |
11/2016 | FRONTEO | Post-IPO Debt | 0 |
6/2016 | Medrx | Post-IPO Debt | 0 |
4/2016 | SymBio Pharmaceuticals | Post-IPO Debt | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|